Kangmei Pharma | 600518 - Creditori Commerciali

Prezzo Delle Azioni
1.72
Cambio Giornaliero
0 0%
Mensile
-2.82%
Annuale
-11.79%
Q2 Previsione
1.71




Creditori Commerciali Cambiamento Data
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Alaunos Therapeutics USD 843K 34K 2025-09
Avita Medical AUD 8.96M 1.69M 2025-12
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Genomma Lab Internacional MXN 3.75B 2.02B 2025-12
Hypermarcas BRL 583.2M 29.42M 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
IQVIA Holdings USD 3.75B 201M 2025-12
Jiangsu Hengrui CNY 2.33B 64.06M 2026-03
Kangmei Pharma CNY 2.61B 176.42M 2025-09
Moderna USD 317M 50M 2025-12
Organon & Co USD 1.07B 7M 2025-09
Revvity USD 185.46M 9.66M 2025-12
Sh Fosun Pharma CNY 4.86B 492.37M 2025-12
Tectonic Therapeutic USD 1.09M 392K 2025-12
Viatris USD 1.33B 6.4M 2025-09
Wuxi Apptec CNY 2.45B 176.85M 2025-12
Xeris Pharmaceuticals USD 3.08M 3.45M 2025-12
Zz Pientze Pharmaceu CNY 516.14M 31.53M 2025-09